Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model

Shigellosis is an acute invasive disease of the lower intestine, which afflicts millions of people worldwide with an estimated one million fatalities per annum. Despite of extensive research during the last two decades, a vaccine against multi-drug resistant Shigella is not yet available in the mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagnik, Bhrugu, Sharma, Drashya, Padh, Harish, Desai, Priti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115592/
https://www.ncbi.nlm.nih.gov/pubmed/31047673
http://dx.doi.org/10.1016/j.vaccine.2019.04.053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115592/
https://www.ncbi.nlm.nih.gov/pubmed/31047673
http://dx.doi.org/10.1016/j.vaccine.2019.04.053

Ejemplares similares